Sarah Cannon Cancer Center (HCA Midwest KC) — Kansas City, Missouri

Sarah Cannon Cancer Center (HCA Midwest KC) is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Center (HCA Midwest KC) has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Karyopharm Therapeutics Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

• Children's Mercy Hospital & Clinics
• Children's Mercy Hospital
• Children's Mercy Hospital - Department of Nephrology
• University of Kansas Medical Center
• University Of Kansas Cancer Center
• University of Missouri - Kansas City / The Children's Mercy Hospital
• University Health Truman Medical Center
• Children's Mercy Hospital/ID# 200221
• Saint Luke's Hospital/Marion Bloch Neuroscience Institute Dept of Regulatory
• VA Medical Center
• Saint Luke's Hospital of Kansas City Mid America
• Section of Pediatric Nephrology, Children's Mercy Hospitals and Clinics

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Center (HCA Midwest KC)?

Sarah Cannon Cancer Center (HCA Midwest KC) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Center (HCA Midwest KC) conducted?

Sarah Cannon Cancer Center (HCA Midwest KC) has 1 clinical trials on record. Their work covers Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is Sarah Cannon Cancer Center (HCA Midwest KC) accredited by Crixeo Clinical Trials?

Sarah Cannon Cancer Center (HCA Midwest KC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Center (HCA Midwest KC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.